Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022.

Klaassen, Fayette; Chitwood, Melanie H; Cohen, Ted; Pitzer, Virginia E; Russi, Marcus; Swartwood, Nicole A; Salomon, Joshua A; Menzies, Nicolas A

Klaassen, Fayette; Chitwood, Melanie H; Cohen, Ted; Pitzer, Virginia E; Russi, Marcus; Swartwood, Nicole A; Salomon, Joshua A; Menzies, Nicolas A.

Afiliação

Klaassen F; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston MA.
Chitwood MH; Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, New Haven CT.
Cohen T; Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, New Haven CT.
Pitzer VE; Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, New Haven CT.
Russi M; Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, New Haven CT.
Swartwood NA; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston MA.
Salomon JA; Department of Health Policy, Stanford University School of Medicine, Stanford CA.
Menzies NA; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston MA.

medRxiv ; 2022 Nov 23.

Article em En | MEDLINE | ID: mdl-36451882

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: MedRxiv Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google